Skip to main content
Total Market Cap: $43,732,033,605 Volume (24h): $739,350,421

22nd Century Group Inc.

22nd Century Group Inc. (XXII) logo
Rank 34
About

The main focus of American company 22nd Century Group is the research, development, and production of low-nicotine smoking solutions. However, in conjunction with a wholly-owned subsidiary Botanical Genetics, they also have a license to supply patients with cannabinoid-based medicine. 22nd Century Group also owns Goodrich Tobacco Company, NASCO Products, and Heracles Pharmaceuticals.

Website
$1.1400
USD
0.88%
Market cap
$143,256,887
Total volume
$658,753
Shares outstanding
125,663,936
Rank 34
Website
About

The main focus of American company 22nd Century Group is the research, development, and production of low-nicotine smoking solutions. However, in conjunction with a wholly-owned subsidiary Botanical Genetics, they also have a license to supply patients with cannabinoid-based medicine. 22nd Century Group also owns Goodrich Tobacco Company, NASCO Products, and Heracles Pharmaceuticals.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
NYSE
XXII
$658,753
100%
$1.1400
Chart
Social media
Tweets by @_xxiicentury
22nd Century Group Inc.

Share widget

Copy widget code
Subscribe to our newsletter